Last reviewed · How we verify
Udenafil 100 mg — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Udenafil 100 mg (Udenafil 100 mg) — Warner Chilcott.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Udenafil 100 mg TARGET | Udenafil 100 mg | Warner Chilcott | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Udenafil 100 mg CI watch — RSS
- Udenafil 100 mg CI watch — Atom
- Udenafil 100 mg CI watch — JSON
- Udenafil 100 mg alone — RSS
Cite this brief
Drug Landscape (2026). Udenafil 100 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/udenafil-100-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab